Goodrx Historical Income Statement

GDRX Stock

USD 8.68 0.11 1.25%

Historical analysis of Goodrx Holdings income statement accounts such as Interest Expense of 39.3 M or Selling General Administrative of 166.7 M can show how well Goodrx Holdings performed in making a profits. Evaluating Goodrx Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Goodrx Holdings's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Goodrx Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Goodrx Holdings is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.

About Goodrx Income Statement Analysis

Goodrx Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Goodrx Holdings shareholders. The income statement also shows Goodrx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Goodrx Holdings Income Statement Chart

At this time, Goodrx Holdings' Non Operating Income Net Other is fairly stable compared to the past year.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts Goodrx Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Goodrx Holdings minus its cost of goods sold. It is profit before Goodrx Holdings operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Goodrx Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Goodrx Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.At this time, Goodrx Holdings' Non Operating Income Net Other is fairly stable compared to the past year.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	34.6M	54.2M	111.8M	117.4M
Interest Income	59K	9.3M	29.1M	30.6M

Depreciation And Amortization Interest Income

Goodrx Holdings income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Non Operating Income Net Other
Tax Provision		-0.05	-0.93	-0.9	-0.63	-0.41	-0.49	-0.52	-0.43	-0.52	0.2	0.19	0.2	-0.49	-0.14	-0.92	-0.44	-0.83	0.48	0.84	0.29	1.0	-0.79
Net Interest Income	-0.05		-0.04	-0.03	-0.63	-0.11	-0.19	-0.18	-0.2	-0.12	-0.06	0.04	-0.06	0.1	-0.07	-0.06	-0.13	-0.05	0.03	0.41	0.04	-0.05	-0.02
Interest Income	-0.93	-0.04		0.98	0.73	0.26	0.61	0.64	0.55	0.54	0.01	0.0	0.01	0.64	0.38	0.98	0.45	0.95	-0.29	-0.91	-0.09	-0.93	0.94
Depreciation And Amortization	-0.9	-0.03	0.98		0.71	0.36	0.74	0.76	0.69	0.67	-0.07	-0.09	-0.08	0.76	0.3	1.0	0.59	0.99	-0.36	-0.92	-0.18	-0.89	0.94
Interest Expense	-0.63	-0.63	0.73	0.71		0.24	0.59	0.62	0.54	0.49	0.04	-0.03	0.04	0.48	0.3	0.73	0.41	0.71	-0.22	-0.9	-0.1	-0.62	0.69
Selling General Administrative	-0.41	-0.11	0.26	0.36	0.24		0.64	0.64	0.67	0.85	-0.94	-0.95	-0.94	0.45	-0.76	0.39	0.88	0.4	-0.98	-0.39	-0.98	-0.42	0.29
Selling And Marketing Expenses	-0.49	-0.19	0.61	0.74	0.59	0.64		1.0	0.99	0.95	-0.4	-0.44	-0.4	0.93	-0.1	0.73	0.92	0.82	-0.55	-0.71	-0.49	-0.49	0.7
Total Revenue	-0.52	-0.18	0.64	0.76	0.62	0.64	1.0		0.99	0.95	-0.39	-0.44	-0.39	0.94	-0.09	0.76	0.92	0.84	-0.56	-0.73	-0.49	-0.52	0.73
Gross Profit	-0.43	-0.2	0.55	0.69	0.54	0.67	0.99	0.99		0.95	-0.43	-0.48	-0.43	0.91	-0.15	0.69	0.94	0.78	-0.57	-0.66	-0.52	-0.43	0.66
Other Operating Expenses	-0.52	-0.12	0.54	0.67	0.49	0.85	0.95	0.95	0.95		-0.66	-0.69	-0.66	0.85	-0.38	0.67	0.99	0.74	-0.78	-0.63	-0.73	-0.52	0.62
Operating Income	0.2	-0.06	0.01	-0.07	0.04	-0.94	-0.4	-0.39	-0.43	-0.66		0.99	1.0	-0.24	0.93	-0.1	-0.71	-0.11	0.95	0.07	0.99	0.22	-0.03
Net Income From Continuing Ops	0.19	0.04	0.0	-0.09	-0.03	-0.95	-0.44	-0.44	-0.48	-0.69	0.99		0.99	-0.26	0.92	-0.12	-0.74	-0.13	0.95	0.12	1.0	0.21	-0.05
Ebit	0.2	-0.06	0.01	-0.08	0.04	-0.94	-0.4	-0.39	-0.43	-0.66	1.0	0.99		-0.24	0.93	-0.1	-0.71	-0.11	0.95	0.07	0.99	0.22	-0.03
Research Development	-0.49	0.1	0.64	0.76	0.48	0.45	0.93	0.94	0.91	0.85	-0.24	-0.26	-0.24		0.05	0.74	0.8	0.84	-0.39	-0.61	-0.31	-0.49	0.77
Ebitda	-0.14	-0.07	0.38	0.3	0.3	-0.76	-0.1	-0.09	-0.15	-0.38	0.93	0.92	0.93	0.05		0.28	-0.46	0.27	0.78	-0.28	0.88	-0.12	0.32
Cost Of Revenue	-0.92	-0.06	0.98	1.0	0.73	0.39	0.73	0.76	0.69	0.67	-0.1	-0.12	-0.1	0.74	0.28		0.6	0.98	-0.39	-0.93	-0.21	-0.91	0.92
Total Operating Expenses	-0.44	-0.13	0.45	0.59	0.41	0.88	0.92	0.92	0.94	0.99	-0.71	-0.74	-0.71	0.8	-0.46	0.6		0.67	-0.81	-0.56	-0.78	-0.44	0.55
Reconciled Depreciation	-0.83	-0.05	0.95	0.99	0.71	0.4	0.82	0.84	0.78	0.74	-0.11	-0.13	-0.11	0.84	0.27	0.98	0.67		-0.38	-0.9	-0.22	-0.83	0.96
Income Before Tax	0.48	0.03	-0.29	-0.36	-0.22	-0.98	-0.55	-0.56	-0.57	-0.78	0.95	0.95	0.95	-0.39	0.78	-0.39	-0.81	-0.38		0.37	0.98	0.49	-0.29
Total Other Income Expense Net	0.84	0.41	-0.91	-0.92	-0.9	-0.39	-0.71	-0.73	-0.66	-0.63	0.07	0.12	0.07	-0.61	-0.28	-0.93	-0.56	-0.9	0.37		0.21	0.84	-0.84
Net Income	0.29	0.04	-0.09	-0.18	-0.1	-0.98	-0.49	-0.49	-0.52	-0.73	0.99	1.0	0.99	-0.31	0.88	-0.21	-0.78	-0.22	0.98	0.21		0.3	-0.13
Income Tax Expense	1.0	-0.05	-0.93	-0.89	-0.62	-0.42	-0.49	-0.52	-0.43	-0.52	0.22	0.21	0.22	-0.49	-0.12	-0.91	-0.44	-0.83	0.49	0.84	0.3		-0.79
Non Operating Income Net Other	-0.79	-0.02	0.94	0.94	0.69	0.29	0.7	0.73	0.66	0.62	-0.03	-0.05	-0.03	0.77	0.32	0.92	0.55	0.96	-0.29	-0.84	-0.13	-0.79

Click cells to compare fundamentals

Goodrx Holdings Account Relationship Matchups

Goodrx Holdings income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	16.9M	(9.8M)	15.1M	9.6M	(50.7M)	(48.2M)
Net Interest Income	(48.9M)	(27.8M)	(23.6M)	(25.0M)	(24.7M)	(25.9M)
Interest Income	715K	160K	59K	9.3M	29.1M	30.6M
Depreciation And Amortization	11.3M	18.6M	34.6M	54.2M	111.8M	117.4M
Interest Expense	49.6M	27.9M	23.6M	34.2M	56.7M	39.3M
Selling General Administrative	14.7M	461.5M	154.7M	144.8M	125.5M	166.7M
Selling And Marketing Expenses	177.0M	255.1M	370.2M	357.6M	341.3M	294.3M
Total Revenue	388.2M	550.7M	745.4M	766.6M	750.3M	632.6M
Gross Profit	374.2M	521.1M	698.7M	701.5M	580.2M	571.8M
Other Operating Expenses	248.5M	826.4M	732.0M	764.8M	698.9M	631.2M
Operating Income	139.7M	(275.7M)	13.4M	11.0M	51.4M	53.9M
Net Income From Continuing Ops	66.0M	(293.6M)	(25.3M)	(32.8M)	15.0M	15.8M
Ebit	139.7M	(275.7M)	13.4M	11.0M	51.4M	53.9M
Research Development	29.3M	61.8M	125.9M	143.1M	133.4M	98.5M
Ebitda	151.0M	(257.1M)	48.0M	65.2M	163.1M	171.3M
Cost Of Revenue	14.0M	29.6M	46.7M	65.1M	170.1M	178.6M
Total Operating Expenses	234.5M	796.8M	685.3M	699.7M	528.8M	570.4M
Reconciled Depreciation	13.6M	18.4M	34.5M	54.2M	79.6M	83.6M
Income Before Tax	83.0M	(303.5M)	(10.2M)	(23.2M)	(55.6M)	(58.4M)
Total Other Income Expense Net	(56.7M)	(27.7M)	(23.6M)	(34.2M)	(106.9M)	(101.6M)
Net Income Applicable To Common Shares	42.4M	(293.6M)	(25.3M)	(32.8M)	(29.5M)	(31.0M)
Net Income	66.0M	(293.6M)	(25.3M)	(32.8M)	(8.9M)	(9.3M)
Income Tax Expense	16.9M	(9.8M)	15.1M	9.6M	(46.7M)	(44.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VTSNX	Vanguard Total International
VBTIX	Vanguard Total Bond
VMCIX	Vanguard Mid Cap Index

Additional Tools for Goodrx Stock Analysis

When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Goodrx Historical Income Statement

About Goodrx Income Statement Analysis

Goodrx Holdings Income Statement Chart

Total Revenue

Gross Profit

Goodrx Holdings income statement Correlations

Goodrx Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Goodrx Holdings income statement Accounts

Also Currently Popular

Additional Tools for Goodrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Tax Expense	+ 1.0	Tax Provision
Cost Of Revenue	+ 1.0	Depreciation And Amortization
Total Revenue	+ 1.0	Selling And Marketing Expenses
Ebit	+ 1.0	Operating Income
Net Income	+ 1.0	Net Income From Continuing Ops
Reconciled Depreciation	+ 0.99	Depreciation And Amortization

Net Income	- 0.98	Selling General Administrative
Income Before Tax	- 0.98	Selling General Administrative
Net Income From Continuing Ops	- 0.95	Selling General Administrative
Ebit	- 0.94	Selling General Administrative
Operating Income	- 0.94	Selling General Administrative
Total Other Income Expense Net	- 0.93	Cost Of Revenue